Accelerating translational life sciences from lab to clinic
We invest in Pre-Seed and Seed stage BioTech and MedTech startups that have demonstrated substantial translational progress with non-dilutive funding. We partner with scientists who have validated their science and are ready to build translational companies.
Portfolio
Active
Clinical-stage company developing non-invasive ultrasound neuromodulation to treat chronic inflammatory disorders by activating the body's natural anti-inflammatory pathways.
Active
Developing the first injectable electrode platform for cardiac rhythm management, using conductive hydrogel to restore electrical conduction across scarred myocardium and enable low-energy, painless defibrillation.
Volumetric
YC W20Rice spinout developing bioprinting for vascular tissue structures.
Acquired by 3D Systems